Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 167244)

Published in J Virol on August 01, 2003

Authors

Nathan J Kelly1, Matthew T Palmer, Casey D Morrow

Author Affiliations

1: Department of Microbiology, University of Alabama at Birmingham, 35294, USA.

Articles cited by this

Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol (1999) 13.27

A detailed model of reverse transcription and tests of crucial aspects. Cell (1979) 8.93

A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis. J Biol Chem (1975) 5.08

Retroviruses. Science (1988) 4.22

A 7 bp mutation converts a human RNA polymerase II snRNA promoter into an RNA polymerase III promoter. Cell (1989) 3.28

Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis. J Virol (1977) 2.99

Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol (1995) 2.47

The role of exportin-t in selective nuclear export of mature tRNAs. EMBO J (1998) 2.40

Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J Virol (1994) 2.37

tRNAs as primer of reverse transcriptases. Biochimie (1995) 2.37

Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol (1986) 2.33

The trials and travels of tRNA. Genes Dev (1999) 2.30

Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys). J Virol (1995) 2.16

A channeled tRNA cycle during mammalian protein synthesis. Proc Natl Acad Sci U S A (1995) 2.13

Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J Virol (1999) 2.08

Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J Virol (1991) 1.97

Channeling of aminoacyl-tRNA for protein synthesis in vivo. Proc Natl Acad Sci U S A (1991) 1.95

Primer tRNAs for reverse transcription. J Virol (1997) 1.90

Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62

Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met). J Virol (1997) 1.60

Replication of avian leukosis viruses with mutations at the primer binding site: use of alternative tRNAs as primers. J Virol (1995) 1.52

Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1. J Virol (2001) 1.41

Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His). Virology (1996) 1.39

In vivo aminoacylation of human and Xenopus suppressor tRNAs constructed by site-specific mutagenesis. Proc Natl Acad Sci U S A (1987) 1.22

Recognition of yeast tRNA(Phe) by its cognate yeast phenylalanyl-tRNA synthetase: an analysis of specificity. Biochemistry (1992) 1.12

Essential regions of the tRNA primer required for HIV-1 infectivity. Nucleic Acids Res (2000) 1.04

Positive and negative functional interactions between promoter elements from different classes of RNA polymerase III-transcribed genes. EMBO J (1990) 1.04

Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol (1997) 1.03

Correlation between tRNALys3 aminoacylation and its incorporation into HIV-1. J Biol Chem (2002) 1.01

Yeast tRNA(Phe) expressed in human cells can be selected by HIV-1 for use as a reverse transcription primer. Virology (2003) 0.92

Complementarity between 3' terminal nucleotides of tRNA and primer binding site is a major determinant for selection of the tRNA primer used for initiation of HIV-1 reverse transcription. Virology (1999) 0.89

Identification of critical elements in the tRNA acceptor stem and T(Psi)C loop necessary for human immunodeficiency virus type 1 infectivity. J Virol (2001) 0.88

Articles by these authors

Emergence of the Th17 pathway and its role in host defense. Adv Immunol (2008) 1.65

Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys (2011) 1.12

Getting started with microbiome analysis: sample acquisition to bioinformatics. Curr Protoc Hum Genet (2014) 1.09

Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther (2014) 1.02

Gastric microbiome and gastric cancer. Cancer J (2014) 0.93

Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replication. J Virol (2003) 0.92

Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site. Virology (2004) 0.92

Yeast tRNA(Phe) expressed in human cells can be selected by HIV-1 for use as a reverse transcription primer. Virology (2003) 0.92

Enhanced functional recovery from spinal cord injury following intrathecal or intramuscular administration of poliovirus replicons encoding IL-10. Virology (2005) 0.86

Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease. Virology (2003) 0.85

HIV type 1 that select tRNA(His) or tRNA(Lys1,2) as primers for reverse transcription exhibit different infectivities in peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (2004) 0.85

Structural elements of the tRNA TPsiC loop critical for nucleocytoplasmic transport are important for human immunodeficiency virus type 1 primer selection. J Virol (2005) 0.84

Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli formula supplied in trans. J Virol (2006) 0.83

Analysis of murine leukemia virus replication complemented by yeast tRNA(Phe) reveals inherent preferences for the tRNA primer selected for reverse transcription. Virology (2004) 0.82

HIV gene expression from intact proviruses positioned in bacterial artificial chromosomes at integration sites previously identified in latently infected T cells. Virology (2010) 0.82

Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells. Retrovirology (2005) 0.82

Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons. Virology (2003) 0.81

Impact of forced selection of tRNAs on HIV-1 replication and genome stability highlight preferences for selection of certain tRNAs. Virus Res (2006) 0.81

Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection. Vaccine (2005) 0.80

Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNA(His) as primer. Nucleic Acids Res (2003) 0.80

tRNA isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral translation. J Virol (2007) 0.78

Mutations in the TPsiC loop of E. coli tRNALys,3 have varied effects on in trans complementation of HIV-1 replication. Virol J (2007) 0.77

Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture. Virology (2005) 0.77

HIV-1 designed to use different tRNAGln isoacceptors prefers to select tRNAThr for replication. Virol J (2006) 0.77

Immunology: narcissistic helpers. Nature (2007) 0.77

Nucleotides within the anticodon stem are important for optimal use of tRNA(Lys,3) as the primer for HIV-1 reverse transcription. Virology (2007) 0.77

The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop. Virology (2006) 0.76

Intramuscular immunization with poliovirus replicons primes for a humoral and cellular immune response to soluble antigen. Viral Immunol (2003) 0.76

Importance of A-loop complementarity with tRNAHis anticodon for continued selection of tRNAHis as the HIV reverse transcription primer. Virol J (2007) 0.76

Forced selection of tRNA(Glu) reveals the importance of two adenosine-rich RNA loops within the U5-PBS for SIV(smmPBj) replication. Virology (2007) 0.75

Analysis of the replication of HIV-1 forced to use tRNAMet(i) supports a link between primer selection, translation and encapsidation. Retrovirology (2007) 0.75

Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy. J Acad Nutr Diet (2016) 0.75